Global Life Science Ventures — Investing in the life sciences

Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than € 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.

Text size

GLSV news

22.04.2008 GLSV receives 2007 Dyodelta European Life Science Innovation Award "Investor of the Year Award" more...

14.04.2008 April 2008 Teil 20 der Serie: Köpfe der deutschsprachigen Private Equity-Szene, Hanns-Peter Wiese, Venture Capial Magazin 4/2008 more...

17.01.2008 GLSV leads investment in Action Pharma A/S more...

06.12.2007 GLSV invests in Pelikan Technologies more...

02.10.2007 Biotech Investment Barometer Reveals Continued Confidence in Sector
more...

More News


Portfolio company news

01.10.2008 MediGene Spins Out mTCR Programme - Independent Company Immunocore Limited Founded more...

29.09.2008 Nitec Pharma AG secures funding of CHF 24M from TVM and Deutsche Bank more...

29.09.2008 Medigene Clinical data for EndoTAG(TM)-1 to be presented at two further medical conferences (DVGS, UEGW) more...

21.09.2008 Coapt Sytems Launches FDA Cleared Novielle Voice(TM) For Restoration Of Voice Loss more...

16.09.2008 MediGene reports positive 12-month survival data for EndoTAG(TM)-1 from Phase II pancreatic cancer study more...

More News